Semaglutide extends lifespan and boosts health in older mice
In a study, semaglutide improved memory, muscle function, blood sugar control, and several biological markers of aging in older healthy mice. The treatment also helped them live longer. These findings suggest potential benefits for aging-related conditions.
Semaglutide, a medication primarily used for type 2 diabetes and weight management, has shown promising anti-aging effects in a recent animal study. Researchers administered the drug to older, healthy mice and observed improvements across multiple physiological systems, including enhanced memory function and better muscle performance. The treatment also improved blood sugar regulation and positively influenced several biological markers associated with the aging process.
The most striking outcome was increased lifespan among treated mice compared to untreated counterparts. While these results are confined to animal models, they add to a growing body of research exploring whether existing metabolic drugs might be repurposed to address age-related decline. The study's focus on older, healthy subjects rather than diseased ones is notable, as it suggests potential preventive applications.
If these findings translate to humans, semaglutide could reshape how aging-related conditions are approached, potentially delaying the onset of cognitive and physical decline in older populations. This may affect healthcare systems by reducing long-term care burdens, though widespread use would require extensive clinical trials. Patients and physicians could gain a new preventive tool, but affordability and accessibility may limit who benefits. The results also raise questions about whether longevity drugs should be used by healthy individuals, not just those with medical conditions.